Announcements Trials
Browse Landscape

Phase

Phase 4 2Phase NA 1Phase 3 1

Status

Completed 4

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Conditions

Polycystic Ovary Syndrome 4Overweight 1Metabolic Syndrome 1Menstruation Disturbances 1Insulin Resistance 1Infertility 1Hyperandrogenism 1

Interventions

Cyclophosphamide 548pembrolizumab 384Radiotherapy 363Bevacizumab 360Carboplatin 351Rituximab 315Cisplatin 300Gemcitabine 297Paclitaxel 288Dexamethasone 272Docetaxel 271fludarabine phosphate 241Doxorubicin 231Nivolumab 220Etoposide 209Cytarabine 203Lenalidomide 201fludarabine 191Oxaliplatin 191Fluorouracil 190Melphalan 189Filgrastim 188Capecitabine 175Calcium Dobesilate 172Radiosurgery 167Erlotinib Hydrochloride 167Methotrexate 163Bortezomib 162Granulocyte Colony-Stimulating Factor 154Whole-Body Irradiation 144

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
OTHER × Has results × drospirenone and ethinyl estradiol combination × Clear all
NCT03819140 2025-11-14

CCOUP

University of California, San Francisco

Phase 4 Completed
51 enrolled 15 charts

Polycystic Ovary Syndrome, Hyperandrogenism

NCT00640224 2017-11-17

Insulin Resistance, Polycystic Ovary Syndrome, and Bone Research Study

University of Pittsburgh

Phase 4 Completed
65 enrolled 28 charts

Polycystic Ovary Syndrome

NCT00714233 2015-05-15

Treatment of Adolescent Polycystic Ovary Syndrome (PCOS)

University of Rochester

Phase 3 Completed
43 enrolled 13 charts

Menstruation Disturbances, Polycystic Ovary Syndrome

NCT00442689 2014-06-06

Metabolic Syndrome in PCOS: Precursors and Interventions

Northwestern University

Phase NA Completed
97 enrolled 13 charts

Infertility, Insulin Resistance, Polycystic Ovary Syndrome, Metabolic Syndrome, Overweight

Data powered by HemOnc (CC BY 4.0) Colophon âš¡